Velocity’s research site in Phoenix frequently conducts clinical trials related, but not limited to, Infectious Diseases, Pediatrics, and Women’s Health. Acquired by Velocity in 2022, this location was founded in 2017 as the third site of MedPharmics Clinical Research.
The site is easily accessible to thousands of patients, including a large group of diverse populations. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Phoenix team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.